SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-23-005337
Filing Date
2023-03-01
Accepted
2023-03-01 07:24:39
Documents
146
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K hznp-20221231.htm   iXBRL 10-K 9724643
2 EX-10.3 hznp-ex10_3.htm EX-10 15143
3 EX-10.13 hznp-ex10_13.htm EX-10 389542
4 EX-10.56 hznp-ex10_56.htm EX-10 14520
5 EX-10.57 hznp-ex10_57.htm EX-10 29765
6 EX-21.1 hznp-ex21_1.htm EX-21 39769
7 EX-23.1 hznp-ex23_1.htm EX-23 5527
8 EX-31.1 hznp-ex31_1.htm EX-31 13894
9 EX-31.2 hznp-ex31_2.htm EX-31 12908
10 EX-32.1 hznp-ex32_1.htm EX-32 10854
11 EX-32.2 hznp-ex32_2.htm EX-32 10746
12 GRAPHIC img127996310_0.jpg GRAPHIC 90265
13 GRAPHIC img127996310_1.jpg GRAPHIC 35270
14 GRAPHIC hznp-ex10_13i0.jpg GRAPHIC 6031
  Complete submission text file 0000950170-23-005337.txt   31892246

Data Files

Seq Description Document Type Size
15 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hznp-20221231_cal.xml EX-101.CAL 118976
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hznp-20221231_pre.xml EX-101.PRE 981252
17 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hznp-20221231_lab.xml EX-101.LAB 1154408
18 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hznp-20221231_def.xml EX-101.DEF 662623
19 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hznp-20221231.xsd EX-101.SCH 156432
140 EXTRACTED XBRL INSTANCE DOCUMENT hznp-20221231_htm.xml XML 6473867
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35238 | Film No.: 23689778
SIC: 2834 Pharmaceutical Preparations